† People involved in the organization of the challenge. ‡ People contributing data from their institutions.§ Equal senior authors.

Pseudoprogression (PsP) is a diagnostic clinical dilemma in cancer. In this study, we retrospectively analyse glioblastoma patients, and using their dynamic susceptibility contrast and dynamic contrast-enhanced perfusion MRI images we build a classifier using radiomic features obtained from both Ktrans and rCBV maps coupled with support vector machines. We achieve an accuracy of 90.82% (area under the curve (AUC) = 89.10%, sensitivity = 91.36%, 67 specificity = 88.24%, p = 0.017) in differentiating between pseudoprogression (PsP) and progressive disease (PD). The diagnostic performances of the models built using radiomic features from Ktrans and rCBV separately were equally high (Ktrans: AUC = 94%, 69 p = 0.012; rCBV: AUC = 89.8%, p = 0.004). Thus, this MR perfusion-based radiomic model demonstrates high accuracy, sensitivity and specificity in discriminating PsP from PD, thus provides a reliable alternative for noninvasive identification of PsP versus PD at the time of clinical/radiologic question. This study also illustrates the successful application of radiomic analysis as an advanced processing step on different MR perfusion maps.

I ntracranial hemorrhage is a potentially life-threatening problem that has many direct and indirect causes. Accuracy in diagnosing the presence and type of intracranial hemorrhage is a critical part of effective treatment. Diagnosis is often an urgent procedure requiring review of medical images by highly trained specialists and sometimes necessitating confirmation through clinical history, vital signs, and laboratory examinations. The process is complicated and requires immediate identification for optimal treatment.Intracranial hemorrhage is a relatively common condition that has many causes, including trauma, stroke, aneurysm, vascular malformation, high blood pressure, illicit drugs, and blood clotting disorders (1). Neurologic consequences can vary extensively from headache to death depending upon the size, type, and location of the hemorrhage. The role of the radiologist is to detect the hemorrhage, characterize the type and cause of the hemorrhage, and to determine if the hemorrhage could be jeopardizing critical areas of the brain that might require immediate surgery.While all acute hemorrhages appear attenuated on CT images, the primary imaging features that help radiologists determine the cause of hemorrhage are the location, shape, and proximity to other structures. Intraparenchymal hemorrhage is blood that is located completely within the brain itself. Intraventricular or subarachnoid hemorrhage is blood that has leaked into the spaces of the brain that normally contain cerebrospinal fluid (the ventricles or subarachnoid cisterns, respectively). Extra-axial hemorrhage is blood that collects in the tissue coverings that surround the brain (eg, subdural or epidural subtypes). It is important to note that patients may exhibit more than one type of cerebral hemorrhage, which may appear on the same image or imaging study. Although small hemorrhages are typically less morbid than large hemorrhages, even a small hemorrhage can lead to death if it is in a critical location. Small hemorrhages also may herald future hemorrhages that could be fatal (eg, ruptured cerebral aneurysm). The presence or absence of hemorrhage may guide specific treatments (eg, stroke).Detection of cerebral hemorrhage with brain CT is a popular clinical use case for machine learning (2-5). Many of these early successful investigations were based upon relatively small datasets (hundreds of examinations) from single institutions. Chilamkurthy et al created a diverse brain CT dataset that was selected from 20 geographically distinct centers in India (more than 21 000 unique examinations). This was used to create smaller randomly selected subsets for validation and testing on common acute brain abnormalities (6). The ability for machine learning algorithms to generalize to "real-world" clinical imaging data from disparate institutions is paramount to successful use in the clinical environment.The intent for this challenge was to provide a large multiinstitutional and multinational dataset to help develop machine learning algorithms that ca...

No abstract

No abstract

Although machine learning (ML) has shown promise across disciplines, out-of-sample generalizability is concerning. This is currently addressed by sharing multi-site data, but such centralization is challenging/infeasible to scale due to various limitations. Federated ML (FL) provides an alternative paradigm for accurate and generalizable ML, by only sharing numerical model updates. Here we present the largest FL study to-date, involving data from 71 sites across 6 continents, to generate an automatic tumor boundary detector for the rare disease of glioblastoma, reporting the largest such dataset in the literature (n = 6, 314). We demonstrate a 33% delineation improvement for the surgically targetable tumor, and 23% for the complete tumor extent, over a publicly trained model. We anticipate our study to: 1) enable more healthcare studies informed by large diverse data, ensuring meaningful results for rare diseases and underrepresented populations, 2) facilitate further analyses for glioblastoma by releasing our consensus model, and 3) demonstrate the FL effectiveness at such scale and task-complexity as a paradigm shift for multi-site collaborations, alleviating the need for data-sharing.

Primary hyperparathyroidism is a systemic endocrine disease that has significant effects on bone remodeling through the action of parathyroid hormone on the musculoskeletal system. ese findings are important as they can aid in distinguishing primary hyperparathyroidism from other forms of metabolic bone diseases and inform physicians regarding disease severity and complications. is pictorial essay compiles bone-imaging features with the aim of improving the diagnosis of skeletal involvement of primary hyperthyroidism.

The ability to non-invasively predict outcomes and monitor treatment response in primary central nervous system lymphoma (PCNSL) is important as treatment regimens are constantly being trialed. The aim of this study was to assess the validity of using apparent diffusion coefficient (ADC) histogram values to predict Ki-67 expression, a tumor proliferation marker, and patient outcomes in PCNSL in both immunocompetent patients and patients living with HIV (PLWH). Qualitative PCNSL magnetic resonance imaging (MRI) characteristics from 93 patients (23 PLWH and 70 immunocompetent) were analyzed, and whole tumor segmentation was performed on the ADC maps. Quantitative histogram analyses of the segmentations were calculated. These measures were compared to PCNSL Ki-67 expression. Progression-free survival (PFS) and overall survival (OS) were analyzed via comparison to the International Primary Central Nervous System Lymphoma Collaboration Group Response Criteria. Associations between ADC measures and clinical outcomes were assessed using univariate and multivariate Cox proportional hazards models. Normalized ADC (nADC)Min, nADCMean, nADC1, nADC5, and nADC15 values were significantly associated with a poorer OS. nADCMax, nADCMean, nADC5, nADC15, nADC75, nADC95, nADC99 inversely correlated with Ki-67 expression. OS was also significantly associated with lesion hemorrhage. PFS was not significantly associated with ADC values but with lesion hemorrhage. ADC histogram values and related parameters can predict the degree of tumor proliferation and patient outcomes for primary central nervous system lymphoma patients and in both immunocompetent patients and patients living with HIV.